YAP regulates the liver size during the fasting-refeeding transition in mice

Xuan Li(Vanderbilt University), Huichang Bi(Southern Medical University), Chenghui Cai(Sun Yat-sen University), Shicheng Fan(Guilin University of Technology), Xinhui Wang(Zhejiang University), Yifei Zhang(Nanjing University of Chinese Medicine), Min Huang(Sun Yat-sen University), Huilin Li(University of Warwick), Yue Gao(Fujian Agriculture and Forestry University), Hangfei Liang(Sun Yat-sen University), Jie Yang(State University of New York)
Acta Pharmaceutica Sinica B
December 20, 2022
10.1016/j.apsb.2022.12.011
Cited by 18

Related Papers

Current trends in drug metabolism and pharmacokinetics
|Acta Pharmaceutica Sinica B|2019|391
Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease
|Diabetes Care|2012|365
AWARE—AWAreness during REsuscitation—A prospective study
|Resuscitation|2014|233
Metabolic Contrasts Between Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes: I. Observations Using the Hyperglycemic Clamp
|Diabetes Care|2018|162
SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation
|Acta Pharmaceutica Sinica B|2020|129